CHAPPER Healthcare Plans to Receive the Presidency of EUROPACCESS

Images Credits: AscellaHealth, LLC

Announcement

CHAPPER Healthcare, as a ascellahealth’s leading pharmaceutical wholesaler, commercialization, and distributor service provider, predicts its presidency of EUROPACCESS, a smart joint venture of seven pharmaceutical service providers throughout Europe. Enabling integration of market and commercialization access solutions to monitor the critical healthcare system across Europe, the EUROPACCESS builds upon the leadership segmentation of CHAPPER healthcare and its long 50-year experience of the urge to support manufacturers in enhancing patient outcomes by improving access to creative therapies. The leadership will bring more power to CHAPPER’s initiatives and transformation ahead.

CHAPPER Healthcare’s Roots and Plans

Chapper Healthcare was founded by a pharmacist, Philip Chapper 1975 has now gained a position and recognition as a trusted partner for pharmaceutical wholesalers, healthcare providers, and manufacturers expanding in more than 75 countries. The company is well trained in supplying and sourcing unlicensed and rare medicines that are hard to access, contributing to known patient programs and access and manage shortages. Chapper Healthcare serves a fully structured, temperature-controlled supply chain logistics a speed. EUROPACCESS, led by Chapper Healthcare, is a robust collaboration including known pharmaceutical service providers throughout Europe, specifying it as: EURAXI (France), Intsel Chimos (France), TETRAGO (Italy), LENIS (Slovenia), PHARMA INTERNATIONAL (Spain), ILAPO (Germany), and CHAPPER Healthcare (United Kingdom).

These seven partners together enable life sciences stakeholders with an easy market entry to the 30 European distribution and healthcare systems networks, expanding further to over 6,000 hospitals. This expanded network accelerates intense local expertise to elevate market access and promise adherence to the regulatory standards. With this integrated network, EUROPACCESS offers a wide range of services designed to contribute to the pharmaceutical product launch, lifecycle management, and distribution. The services consist of pharmacovigilance, quality assurance, reporting to national health authorities, product launch and market access strategy, temperature-controlled storage and logistics, dossier submission and regulatory filings, and reporting to national health authorities. Also, data collection and analysis for outcomes reporting and localized marketing, medical science liaison, and sales support.

Chapper said, “Our leadership in EUROPACCESS mirrors our commitment to deliver service potency and meet the needs of patients and their support systems. We are forming a responsive, personalized, and resilient pharmaceutical distribution model that serves real impact.”

Chairman and president of Ascellahealth, Bill Oldham, said, “Assuming leadership of EUROPACCESS symbolizes a prominent milestone for Ascellahealth. We together are committed to transitioning pharmaceutical access in Europe with safe, patient-centric, and timely solutions.”